Zhiyuan Robotics Confirms Hong Kong IPO Plans After Previous Denials

iconChainthink
Share
AI summary iconSummary
Zhiyuan Robotics confirmed its Hong Kong IPO plans on July 24, 2026, according to on-chain data and ChainThink. The AI robotics company, which previously denied listing plans twice in the past year, has appointed CITIC Securities, CICC, and Morgan Stanley as underwriters. Omdia forecasts that Zhiyuan will ship 5,168 humanoid robots in 2025, leading the global market. With UBTech Robotics recently approved for a STAR Market IPO, altcoins to watch may include those linked to the robotics and AI sectors.

ChainThink reports that on July 24, Agi Innovation announced it has initiated the process for a Hong Kong listing. This general-purpose AI robotics company, founded three years ago, previously denied rumors of a Hong Kong listing twice last year; this marks its first official confirmation of advancing toward a Hong Kong IPO.

Currently, Zhìyuán has not disclosed the filing date, fundraising amount, or target valuation. According to the South China Morning Post, the company has appointed CICC, CITIC Securities, and Morgan Stanley as lead underwriters; Zhìyuán has not confirmed these details.

According to Omdia data, AgiBot shipped 5,168 humanoid robots in 2025, accounting for approximately 39% of the global market and ranking first in shipment volume. This month, Unitree Technology has received approval for its IPO registration on the STAR Market, bringing both leading robotics companies to the listing stage.

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.